Enhancement of Norepinephrine-induced Transient Contraction in Aortic Smooth Muscle of Diabetic Mice

Acta Medica Okayama

Volumn 57, Issue 1, 2003, Pages 45-48

  Abe, Asaki ^a   Kawasoe, Chiaki ^a   Kondo, Yasuhiro ^a   Sato, Katsunori ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Norepinephrine; Vascular smooth muscle

Indexed keywords

ALLOXAN; CALCIUM; EGTAZIC ACID; ETHYLENE GLYCOL; NORADRENALIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEFICIENCY; CALCIUM TRANSPORT; CONTROLLED STUDY; INCUBATION TIME; MALE; MOUSE; NONHUMAN; REDUCTION; SMOOTH MUSCLE CONTRACTION; SPECIES COMPARISON; ANIMAL; AORTA; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE;

EID: 0042285949     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ozturk Y, Altan VM and Yildizoglu-Ari N: Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev (1996) 48: 69-112.
2. Abe A, Kawazoe C, Kondo Y and Sato K: Vascular responsiveness in alloxan-Induced diabetes-susceptible (ALS) and resistant (ALR) mice. J Vet Med Sci (1998) 60: 1119-1125.
3. Karaki H, Kubota H and Urakawa N: Mobilization of stored calcium for phasic contractions induced by norepinephrine in rabbit aorta. Eur J Pharmacol (1979) 56: 237-245.
4. Berridge MJ and Irvine RF: Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 312: 315-321.
5. Sekiguchi F, Ishibashi K, Katoh H, Kawamoto Y and Ino T: Genetic profile of alloxan-induced diabetes-susceptible mice (ALS) and resistant mice (ALR). Exp Anim (1990) 39: 269-272.
6. Abe A and Karaki H: Inhibitory effects of forskolin on vascular smooth muscle of rabbit aorta. Jpn J Pharmacol (1988) 46: 293-301.
7. Abebe W, Harris KH and MacLeod KM: Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol (1990) 16: 239-248.
8. Head RJ, Longhurst PA, Panek RL and Stitzel RE: A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol (1987) 91: 275-286.
9. Taylor PD, Wickenden AD, Mirrlees DJ and Poston L: Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin- induced diabetes: Effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmacol (1994) 111: 42-48.
10. Rinaldi GJ and Cingolani HE: Effect of diabetes on fast response to norepinephrine in rat aorta. Diabetes (1992) 41: 30-34.
11. 2+-free medium. Eur J Pharmacol (1994) 256: 215-219.
12. 2+ uptake and selective depression of the sustained noradrenergic contraction. Diabetes Metab (2001) 27: 40-48.
13. Abebe W and MacLeod KM: Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can J Physiol Pharmacol (1991) 69: 355-361.
14. Mokuda O, Okazaki R and Sakamoto Y: The early phase of calcipenia-induced parathyroid hormone secretion is blunted in vasculary perfused parathyroid glands of streptozotocin-diabetic rats. Diabetes Metab (2001) 27: 129-31.
15. 2+ overload. J Physiol (2000) 527: 85-94.